** Medical device maker Baxter's BAX.N shares fall 1.2% to $35.60 premarket
** Company forecasts annual adj profit per share between $2.90 and $2.94, vs prior forecast range of $2.93 to $3.01
** Analysts expect full-year profit of $2.95 per share - LSEG
** Baxter expects Q4 sales to be negatively impacted by about $200 mln due to hurricane impact
** Company reports Q3 adj profit of 80 cents/shr vs est 78 cents/shr
** Q3 sales of $3.85 bln in line with est
** As of last close, stock down 6.8% YTD
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru)
((Christy.Santhosh@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。